Lombard Medical Technologies


Lombard Medical Technologies is a medical devices developer in the area of vascular disease. The main product is Aorfix, an endovascular stent graft for the treatment of abdominal aortic aneurysms. The company's main subsidiary originally joined Aim in October 2000 as a shell and acquired its core business in April 2001. LMT was formed to take that business private in 2003. LMT joined Aim on 13 December 2005. At that point it raised £26.2m gross - £23.9m net - at 159p a share. A selling shareholder raised £300,000 at the same time. At the beginning of 2008, £7.6m gross - £7.1m net - was raised at 14p a share. In October 2008, LMT raised £1.7m from a convertible loan note issue. - which was converted at 2.5p a share. This was because of a fund raising of up to £7.8m at 1p a share and £500,000 via five-year convertible loan notes.

Sector: Health

News blog

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds